Crisis-Management-open-access
Crisis management is an integral component of effective reputation management. Protiviti’s Jim DeLoach discusses why it’s imperative to create a rapid-response crisis management capability for sudden and unexpected high-impact, high-velocity and high-persistence events. Years ago, I had a conversation with a high-profile board chair of a top U.S. university. He told me that he et al. in his profession (he was a lawyer) had concerns that organizations, both public and personal , appeared to “relearn” an equivalent lessons over and over with none marked improvement in their preparedness for the unexpected. We hit it off pretty much during this dialogue because this issue is one to which I even have given much thought over the years, particularly since the worldwide financial crisis. We agreed that the danger assessment process should inform the crisis management process. As no brand is resistant to a crisis, it’s evident today that crisis management is an integral component of effective reputation management. A rapid and effective response to a sudden and unexpected event can actually enhance reputation, as astute observers know that even the foremost respected organizations can and can be tested over time. Within the corporate world, however, the unprepared pay a high price.
High Impact List of Articles
-
Analysis of the Current Clinical Research Management System of Investigator Initiated Trials in China
Ye Cao, Xin Wang, Yu Cao, Fuyu Song, Silvia Minelli, Jibin Li, Kexin Li, Minghuang Hong
Research Paper: Clinical Investigation
-
Analysis of the Current Clinical Research Management System of Investigator Initiated Trials in China
Ye Cao, Xin Wang, Yu Cao, Fuyu Song, Silvia Minelli, Jibin Li, Kexin Li, Minghuang Hong
Research Paper: Clinical Investigation
-
Pan-Asian clinical research coordination: challenges and opportunities
Karen Wai Kar Luen, Ken J Lee
Editorial: Clinical Investigation
-
Pan-Asian clinical research coordination: challenges and opportunities
Karen Wai Kar Luen, Ken J Lee
Editorial: Clinical Investigation
-
Novel immunotherapeutic agents for castration-resistant prostate cancer: update from clinical trials
Nishith Singh, Ravi Madan, James L Gulley
Review: Clinical Trail Outcomes: Clinical Investigation
-
Novel immunotherapeutic agents for castration-resistant prostate cancer: update from clinical trials
Nishith Singh, Ravi Madan, James L Gulley
Review: Clinical Trail Outcomes: Clinical Investigation
-
Denosumab in the treatment of bone metastases
EJ Woodward, JE Brown
Review: Clinical Trail Outcomes: Clinical Investigation
-
Denosumab in the treatment of bone metastases
EJ Woodward, JE Brown
Review: Clinical Trail Outcomes: Clinical Investigation
-
Zoledronic acid in conjunction with chemotherapy: bisphosphonate gives fresh hope for newly diagnosed multiple myeloma patients
News and Views: Clinical Investigation
-
Zoledronic acid in conjunction with chemotherapy: bisphosphonate gives fresh hope for newly diagnosed multiple myeloma patients
News and Views: Clinical Investigation
Relevant Topics in Clinical